Countdown to FMC Technologies (FTI) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS

21.10.25 15:15 Uhr

Werte in diesem Artikel
Aktien

26,33 EUR 0,36 EUR 1,39%

47,07 EUR 0,12 EUR 0,26%

34,62 EUR 0,71 EUR 2,09%

Indizes

PKT PKT

2.046,9 PKT 4,7 PKT 0,23%

2.141,7 PKT 6,1 PKT 0,28%

24.308,8 PKT 68,9 PKT 0,28%

9.107,1 PKT 25,8 PKT 0,28%

1.927,3 PKT 7,0 PKT 0,37%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

201,5 PKT 0,4 PKT 0,19%

601,1 PKT 2,6 PKT 0,44%

12.757,7 PKT 25,5 PKT 0,20%

24.314,0 PKT -11,0 PKT -0,05%

24.318,2 PKT 123,4 PKT 0,51%

9.371,7 PKT 19,9 PKT 0,21%

16.346,9 PKT -75,8 PKT -0,46%

1.854,4 PKT -8,4 PKT -0,45%

In its upcoming report, FMC Technologies (FTI) is predicted by Wall Street analysts to post quarterly earnings of $0.65 per share, reflecting an increase of 1.6% compared to the same period last year. Revenues are forecasted to be $2.62 billion, representing a year-over-year increase of 11.4%.The current level reflects a downward revision of 0.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.Bearing this in mind, let's now explore the average estimates of specific FMC Technologies metrics that are commonly monitored and projected by Wall Street analysts.The consensus among analysts is that 'Revenue- Subsea Technologies' will reach $2.28 billion. The estimate indicates a year-over-year change of +12.5%.Analysts forecast 'Revenue- Surface Technologies' to reach $325.10 million. The estimate indicates a change of +1.5% from the prior-year quarter.The collective assessment of analysts points to an estimated 'Revenue- Lease' of $71.81 million. The estimate suggests a change of +13.6% year over year.The combined assessment of analysts suggests that 'Revenue- Product' will likely reach $959.53 million. The estimate points to a change of +20.9% from the year-ago quarter.Analysts expect 'Revenue By Geography- Surface Technologies - Europe and Central Asia' to come in at $31.16 million. The estimate indicates a change of -1.1% from the prior-year quarter.According to the collective judgment of analysts, 'Revenue By Geography- Surface Technologies - Africa' should come in at $11.08 million. The estimate suggests a change of +33.4% year over year.Analysts' assessment points toward 'Revenue By Geography- Surface Technologies- North America' reaching $105.75 million. The estimate suggests a change of -7.9% year over year.It is projected by analysts that the 'Revenue By Geography- Surface Technologies - Middle East' will reach $116.93 million. The estimate indicates a year-over-year change of +2.8%.The average prediction of analysts places 'Inbound Orders - Subsea Technologies' at $2.45 billion. The estimate compares to the year-ago value of $2.46 billion.The consensus estimate for 'Order Backlog - Subsea Technologies' stands at $15.90 billion. The estimate compares to the year-ago value of $13.73 billion.Based on the collective assessment of analysts, 'Order Backlog - Total' should arrive at $16.73 billion. Compared to the present estimate, the company reported $14.70 billion in the same quarter last year.Analysts predict that the 'Order Backlog - Surface Technologies' will reach $805.47 million. The estimate is in contrast to the year-ago figure of $966.80 million. View all Key Company Metrics for FMC Technologies here>>> FMC Technologies shares have witnessed a change of -5.9% in the past month, in contrast to the Zacks S&P 500 composite's +1.2% move. With a Zacks Rank #2 (Buy), FTI is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report TechnipFMC plc (FTI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: FMC und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf FMC

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf FMC

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Fresenius Medical Care (FMC) St.

Wer­bung

Analysen zu Fresenius Medical Care (FMC) St.

DatumRatingAnalyst
20.10.2025Fresenius Medical Care (FMC) St Market-PerformBernstein Research
20.10.2025Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
17.10.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
01.10.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
15.09.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
DatumRatingAnalyst
15.08.2025Fresenius Medical Care (FMC) St KaufenDZ BANK
06.08.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
14.07.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
23.06.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
18.06.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
20.10.2025Fresenius Medical Care (FMC) St Market-PerformBernstein Research
20.10.2025Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
06.08.2025Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
05.08.2025Fresenius Medical Care (FMC) St NeutralUBS AG
21.07.2025Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
DatumRatingAnalyst
17.10.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
01.10.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
15.09.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
10.09.2025Fresenius Medical Care (FMC) St SellUBS AG
02.09.2025Fresenius Medical Care (FMC) St SellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care (FMC) St. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen